Skip to main content
. 2021 Jan 4;22:4. doi: 10.1186/s12891-020-03831-z

Table 7.

Agreement on treatment between ESPs, OSs and common decision

Agreement
Number
(Percent, [95% CI])
Risk differencea
Percent point [95% CI]
(p-value)
ESP
(n = 68)
OS
(n = 69)
Total treatment agreement (3 categories) 60 (88, [81; 96]) 67 (97, [93; 101]) −9 [−17.5; − 0.3] (0.04)
Physiotherapy 55 (81, [72; 90]) 60 (87, [79; 95]) −6 [−18; 6] (0.33)
Steroid injection 55 (81, [72; 90]) 62 (90, [83; 97]) −9.0 [− 21; 3] (0.13)
Diagnostic imaging 58 (85, [77; 94]) 66 (96, [91; 100]) −10 [− 20; − 1] (0.04)
Surgery 65 (96, [91; 101]) 67 (97, [93; 101]) −2 [− 8; 5] (0.64)
No intervention 68 (100, [NA]) 69 (100, [NA]) NA
Total treatment agreement (15 categories) 38 (56, [44; 68]) 52 (75, [65; 86]) −20 [−35; −4] (0.01)
Partial treatment agreement (15 categories) 67 (99, [96; 101]) 68 (99, [96; 101]) −0 [−4: 4] (0.99)

ESP Extended Scope Physiotherapist, OS Orthopaedic surgeon

aDifference in percent point between ESPs and OSs with ESPs as reference (ESP-OS)